Le Lézard
Classified in: Health
Subject: PLW

Biocoat, Inc.'s HYDAK® UV Hydrophilic Coating Awarded USPTO Patent


HORSHAM, Pa., July 26, 2022 /PRNewswire/ -- Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical devices, today announced that its HYDAK® UV coating has been approved for a patent by the United States Patent and Trademark Office (USPTO).

"Biocoat's HYDAK UV coating is built on a bi-laminar platform that offers industry-leading results in lubricity, durability and particulates, which are the main criteria for measuring hydrophilic coating performance," said Dr. Bob Hergenrother, Biocoat's Vice President of Research, Development, and Innovation. "The acceptance of our USPTO filing confirms that our unique and proprietary technology is unmatched in the marketplace."

Biocoat is the only hydrophilic coating provider to offer industry-leading performance using both UV and Thermal Heat curing systems. UV cure coatings are used on many medical devices that require a hydrophilic coating, particularly in the cardiovascular market. Thermal curing is often used on interventional medical devices that require extremely high-performance results. In addition, Thermal curing may be used for coating the inner diameter of the substrate materials or for use on the delivery cartridges used to place intraocular lenses (IOLs).

"Our HYDAK UV coating was introduced to the market in early 2020 and since then, we have had significant interest from both current and new customers" said Jim Moran, President, and CEO, Biocoat. "The entire Biocoat team has worked tirelessly to support this new product launch, and we are proud to be recognized by this patent for our innovation. Our team is laser focused on ensuring that we offer customers the best hydrophilic coatings and product development support available in the industry today".

Scott Cramer, Board Chair for Biocoat, added, "The Biocoat team continues to innovate, which has pushed the organization to be recognized as the leading full-service hydrophilic coating company in the medical device industry."

About Biocoat, Inc.

Biocoat, Inc. is a full-service coatings provider specializing in supplying lubricious hydrophilic coatings custom engineered to meet specific clinical parameters for medical devices to original equipment manufacturers, start-up companies, and contract manufacturers. Biocoat also provides coating services and dip-coating equipment to medical device companies that require assistance with manufacturing.

To learn more about Biocoat visit www.biocoat.com, call +1 215-734-0888 or connect on LinkedIn and Twitter.

SOURCE Biocoat, Inc.


These press releases may also interest you

at 05:06
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Personalized Nutrition Market ? (By Purchase Model (Subscription, One Time Purchase), By End-users (Direct Consumers, Wellness & Fitness Centers,...

at 05:04
The global cell therapy market size is estimated to grow by USD 31041.49 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of 57.06% during the forecast period. ...

at 05:00
May 15, 2024 Amsterdam, the Netherlands ? Royal Philips , today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based on the volume weighted average...

at 04:31
Allied Market Research published a report, titled, "Prosthetic Heart Valve Market by Product (Mechanical Heart Valve, Tissue Heart Valve, and Transcatheter Heart Valve): Global Opportunity...

at 04:30
In industries like pharmaceuticals, food, and logistics, maintaining the integrity of products throughout the supply chain is critical. Temperature and humidity are two key parameters that can significantly affect the quality and safety of goods,...

at 04:25
Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the appointment of Hazel Jones as Chief Executive Officer, after a...



News published on and distributed by: